These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 21616717)
1. Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma. Kelemen LE; Köbel M Lancet Oncol; 2011 Oct; 12(11):1071-80. PubMed ID: 21616717 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms. McCluggage WG J Clin Pathol; 2012 Jul; 65(7):596-600. PubMed ID: 21768188 [TBL] [Abstract][Full Text] [Related]
3. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447 [TBL] [Abstract][Full Text] [Related]
4. Pathology of primary and metastatic mucinous ovarian neoplasms. Leen SL; Singh N J Clin Pathol; 2012 Jul; 65(7):591-5. PubMed ID: 22075188 [TBL] [Abstract][Full Text] [Related]
5. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas. Feltmate CM; Lee KR; Johnson M; Schorge JO; Wong KK; Hao K; Welch WR; Bell DA; Berkowitz RS; Mok SC Clin Cancer Res; 2005 Nov; 11(21):7651-7. PubMed ID: 16278384 [TBL] [Abstract][Full Text] [Related]
6. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification. Yemelyanova AV; Vang R; Judson K; Wu LS; Ronnett BM Am J Surg Pathol; 2008 Jan; 32(1):128-38. PubMed ID: 18162780 [TBL] [Abstract][Full Text] [Related]
7. Mucinous tumors of the ovary: a review. Hart WR Int J Gynecol Pathol; 2005 Jan; 24(1):4-25. PubMed ID: 15626914 [TBL] [Abstract][Full Text] [Related]
8. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II. Young RH Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813 [TBL] [Abstract][Full Text] [Related]
9. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Park SY; Kim HS; Hong EK; Kim WH Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811 [TBL] [Abstract][Full Text] [Related]
10. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. Hanski C; Hofmeier M; Schmitt-Gräff A; Riede E; Hanski ML; Borchard F; Sieber E; Niedobitek F; Foss HD; Stein H; Riecken EO J Pathol; 1997 Aug; 182(4):385-91. PubMed ID: 9306958 [TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability in sporadic mucinous colorectal carcinomas: relationship to clinico-pathological variables. Messerini L; Vitelli F; De Vitis LR; Mori S; Calzolari A; Palmirotta R; Calabrò A; Papi L J Pathol; 1997 Aug; 182(4):380-4. PubMed ID: 9306957 [TBL] [Abstract][Full Text] [Related]
12. Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary. Cao D; Ji H; Ronnett BM Int J Gynecol Pathol; 2005 Jan; 24(1):67-72. PubMed ID: 15626919 [TBL] [Abstract][Full Text] [Related]
13. Mucinous carcinomas of the colorectum have distinct molecular genetic characteristics. Song GA; Deng G; Bell I; Kakar S; Sleisenger MH; Kim YS Int J Oncol; 2005 Mar; 26(3):745-50. PubMed ID: 15703832 [TBL] [Abstract][Full Text] [Related]
14. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features. Leopoldo S; Lorena B; Cinzia A; Gabriella DC; Angela Luciana B; Renato C; Antonio M; Carlo S; Cristina P; Stefano C; Maurizio T; Luigi R; Cesare B Ann Surg Oncol; 2008 May; 15(5):1429-39. PubMed ID: 18301950 [TBL] [Abstract][Full Text] [Related]
15. III. Ovarian cancer 2. Treatment strategy for mucinous adenocarcinoma of the ovary. Gan To Kagaku Ryoho; 2012 Feb; 39(2):202-205. PubMed ID: 22545288 [No Abstract] [Full Text] [Related]
16. Natural history and outcome of mucinous carcinoma of the ovary. Schiavone MB; Herzog TJ; Lewin SN; Deutsch I; Sun X; Burke WM; Wright JD Am J Obstet Gynecol; 2011 Nov; 205(5):480.e1-8. PubMed ID: 21861962 [TBL] [Abstract][Full Text] [Related]
17. [Epidemiological study, pathologic evaluation and prognostic factors of colorectal mucinous vs non-mucinous adenocarcinoma (a series of 196 patients)]. Arfaoui Toumi A; Kriaa Ben Mahmoud L; Khiari M; Lahmer A; Gharbi L; Dhraïef M; Khalfallah T; Regaya Mzabi S; Bouraoui S Tunis Med; 2010 Jan; 88(1):12-7. PubMed ID: 20415207 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics of mucinous adenocarcinoma of the ovary. Shimada M; Kigawa J; Ohishi Y; Yasuda M; Suzuki M; Hiura M; Nishimura R; Tabata T; Sugiyama T; Kaku T Gynecol Oncol; 2009 Jun; 113(3):331-4. PubMed ID: 19275957 [TBL] [Abstract][Full Text] [Related]